IRIS Accounts Production v23.4.0.336 04604636 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh046046362022-03-31046046362023-03-31046046362022-04-012023-03-31046046362021-03-31046046362021-04-012022-03-31046046362022-03-3104604636ns15:EnglandWales2022-04-012023-03-3104604636ns14:PoundSterling2022-04-012023-03-3104604636ns10:Director12022-04-012023-03-3104604636ns10:PrivateLimitedCompanyLtd2022-04-012023-03-3104604636ns10:SmallEntities2022-04-012023-03-3104604636ns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3104604636ns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3104604636ns10:SmallCompaniesRegimeForAccounts2022-04-012023-03-3104604636ns10:FullAccounts2022-04-012023-03-310460463612022-04-012023-03-3104604636ns10:Director22022-04-012023-03-3104604636ns10:Director32022-04-012023-03-3104604636ns10:CompanySecretary12022-04-012023-03-3104604636ns10:RegisteredOffice2022-04-012023-03-3104604636ns5:CurrentFinancialInstruments2023-03-3104604636ns5:CurrentFinancialInstruments2022-03-3104604636ns5:Non-currentFinancialInstruments2023-03-3104604636ns5:Non-currentFinancialInstruments2022-03-3104604636ns5:ShareCapital2023-03-3104604636ns5:ShareCapital2022-03-3104604636ns5:SharePremium2023-03-3104604636ns5:SharePremium2022-03-3104604636ns5:RetainedEarningsAccumulatedLosses2023-03-3104604636ns5:RetainedEarningsAccumulatedLosses2022-03-3104604636ns5:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3104604636ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2022-04-012023-03-3104604636ns5:PlantMachinery2022-04-012023-03-3104604636ns5:IntangibleAssetsOtherThanGoodwill2022-03-3104604636ns5:IntangibleAssetsOtherThanGoodwill2023-03-3104604636ns5:IntangibleAssetsOtherThanGoodwill2022-03-3104604636ns5:PlantMachinery2022-03-3104604636ns5:PlantMachinery2023-03-3104604636ns5:PlantMachinery2022-03-3104604636ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3104604636ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-31
REGISTERED NUMBER: 04604636 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2023

for

DanMedical Limited

DanMedical Limited (Registered number: 04604636)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


DanMedical Limited

Company Information
for the Year Ended 31 March 2023







DIRECTORS: I G M Drysdale
D M Williams
Mrs K R Drysdale





SECRETARY: Mrs K R Drysdale





REGISTERED OFFICE: 12 Threshers Yard
Kingham
Chipping Norton
Oxfordshire
OX7 6YF





REGISTERED NUMBER: 04604636 (England and Wales)





ACCOUNTANTS: Potts & Co
Accountancy & Business Advice
6 Jacobs Yard
Middle Barton
Oxfordshire
OX7 7BY

DanMedical Limited (Registered number: 04604636)

Balance Sheet
31 March 2023

31.3.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - 3,179
Tangible assets 5 16,638 22,024
16,638 25,203

CURRENT ASSETS
Stocks 111,618 102,221
Debtors 6 143,218 39,831
Cash at bank 75,472 46,950
330,308 189,002
CREDITORS
Amounts falling due within one year 7 78,562 109,145
NET CURRENT ASSETS 251,746 79,857
TOTAL ASSETS LESS CURRENT
LIABILITIES

268,384

105,060

CREDITORS
Amounts falling due after more than one
year

8

(18,351

)

(26,311

)

PROVISIONS FOR LIABILITIES (3,161 ) (1,457 )
NET ASSETS 246,872 77,292

CAPITAL AND RESERVES
Called up share capital 296 296
Share premium 49,904 49,904
Retained earnings 196,672 27,092
246,872 77,292

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

DanMedical Limited (Registered number: 04604636)

Balance Sheet - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 April 2024 and were signed on its behalf by:





I G M Drysdale - Director


DanMedical Limited (Registered number: 04604636)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

DanMedical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

DanMedical Limited (Registered number: 04604636)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2022 - 5 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 April 2022
and 31 March 2023 69,769
AMORTISATION
At 1 April 2022 66,590
Charge for year 3,179
At 31 March 2023 69,769
NET BOOK VALUE
At 31 March 2023 -
At 31 March 2022 3,179

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2022 75,147
Additions 161
At 31 March 2023 75,308
DEPRECIATION
At 1 April 2022 53,123
Charge for year 5,547
At 31 March 2023 58,670
NET BOOK VALUE
At 31 March 2023 16,638
At 31 March 2022 22,024

DanMedical Limited (Registered number: 04604636)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Trade debtors 133,360 32,370
Other debtors 9,858 7,461
143,218 39,831

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Bank loans and overdrafts 8,200 8,200
Trade creditors 10,808 78,260
Taxation and social security 51,010 18,729
Other creditors 8,544 3,956
78,562 109,145

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.3.23 31.3.22
£    £   
Bank loans 18,351 26,311